Cargando…
Solid Lipid Nanoparticle Carrier Platform Containing Synthetic TLR4 Agonist Mediates Non-Viral DNA Vaccine Delivery
There is a growing demand for better delivery systems to improve the stability and efficacy of DNA vaccines. Here we report the synthesis of a non-viral DNA vaccine delivery system using a novel adjuvanted solid lipid nanoparticle (SLN-A) platform as a carrier for a DNA vaccine candidate encoding th...
Autores principales: | Francis, Jasmine E., Skakic, Ivana, Dekiwadia, Chaitali, Shukla, Ravi, Taki, Aya C., Walduck, Anna, Smooker, Peter M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563538/ https://www.ncbi.nlm.nih.gov/pubmed/32967285 http://dx.doi.org/10.3390/vaccines8030551 |
Ejemplares similares
-
An Evaluation of Urease A Subunit Nanocapsules as a Vaccine in a Mouse Model of Helicobacter pylori Infection
por: Skakic, Ivana, et al.
Publicado: (2023) -
Small Wonders—The Use of Nanoparticles for Delivering Antigen
por: Taki, Aya, et al.
Publicado: (2015) -
Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists
por: Birmachu, Woubalem, et al.
Publicado: (2007) -
Physicochemical characterization of biological and synthetic forms of two lipid A-based TLR4 agonists
por: Hu, Gang, et al.
Publicado: (2023) -
Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants
por: Shanmugam, Arulkumaran, et al.
Publicado: (2012)